DOTTA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 21.343
EU - Europa 14.743
AS - Asia 7.459
SA - Sud America 1.341
AF - Africa 160
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 16
Totale 45.098
Nazione #
US - Stati Uniti d'America 21.170
GB - Regno Unito 3.231
CN - Cina 2.918
RU - Federazione Russa 2.844
SG - Singapore 2.300
IT - Italia 2.078
IE - Irlanda 2.041
UA - Ucraina 1.250
BR - Brasile 1.148
SE - Svezia 991
HK - Hong Kong 731
DE - Germania 684
FR - Francia 627
KR - Corea 484
FI - Finlandia 390
VN - Vietnam 331
IN - India 201
ES - Italia 163
NL - Olanda 91
CA - Canada 85
BE - Belgio 79
TR - Turchia 78
BD - Bangladesh 69
AR - Argentina 56
MX - Messico 54
AT - Austria 52
JP - Giappone 46
IQ - Iraq 44
PK - Pakistan 43
CI - Costa d'Avorio 39
PL - Polonia 39
ZA - Sudafrica 35
EC - Ecuador 34
IR - Iran 33
AU - Australia 31
CO - Colombia 27
SA - Arabia Saudita 26
ID - Indonesia 25
CZ - Repubblica Ceca 24
CL - Cile 20
LT - Lituania 20
VE - Venezuela 20
MA - Marocco 19
EG - Egitto 18
GR - Grecia 17
JO - Giordania 17
RO - Romania 16
AE - Emirati Arabi Uniti 14
CH - Svizzera 14
DK - Danimarca 14
HU - Ungheria 14
KE - Kenya 14
PE - Perù 14
IL - Israele 13
EU - Europa 12
PT - Portogallo 12
PY - Paraguay 12
UZ - Uzbekistan 9
DO - Repubblica Dominicana 8
ET - Etiopia 8
BY - Bielorussia 7
DZ - Algeria 7
JM - Giamaica 7
MY - Malesia 7
AL - Albania 6
KG - Kirghizistan 6
NP - Nepal 6
PH - Filippine 6
TN - Tunisia 6
AM - Armenia 5
AZ - Azerbaigian 5
BB - Barbados 5
EE - Estonia 5
LU - Lussemburgo 5
MD - Moldavia 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CR - Costa Rica 4
KZ - Kazakistan 4
LB - Libano 4
NO - Norvegia 4
TH - Thailandia 4
UY - Uruguay 4
BG - Bulgaria 3
BN - Brunei Darussalam 3
CY - Cipro 3
IM - Isola di Man 3
KW - Kuwait 3
MU - Mauritius 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
OM - Oman 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
HN - Honduras 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PA - Panama 2
Totale 45.065
Città #
Dallas 3.120
Southend 2.888
Fairfield 2.662
Dublin 2.023
Houston 1.613
Ashburn 1.546
Chandler 1.256
Singapore 1.229
Woodbridge 1.186
Jacksonville 998
Seattle 994
Wilmington 944
Cambridge 901
Moscow 790
Beijing 728
Hong Kong 723
Santa Clara 653
Ann Arbor 547
Siena 472
Hefei 468
Seoul 457
Princeton 455
Nanjing 355
Florence 217
Los Angeles 215
New York 205
The Dalles 190
Boardman 170
Milan 159
Helsinki 142
San Diego 142
Munich 135
San Mateo 132
Nanchang 124
Málaga 122
Buffalo 108
Council Bluffs 105
São Paulo 102
Dong Ket 99
Columbus 95
Shanghai 94
Rome 93
Ho Chi Minh City 71
Redondo Beach 70
Changsha 69
Shenyang 67
London 63
Tianjin 59
Atlanta 58
Bengaluru 55
Hebei 54
Hanoi 52
Dearborn 51
Jiaxing 49
Kunming 48
Zhengzhou 45
Brussels 40
Abidjan 39
Chicago 39
San Francisco 39
Falls Church 38
Nuremberg 38
Norwalk 37
Turku 37
Guangzhou 35
Warsaw 34
Rio de Janeiro 33
Tokyo 33
Toronto 32
Washington 31
Düsseldorf 30
Phoenix 30
Belo Horizonte 29
Montreal 29
Fremont 28
Vienna 28
Brooklyn 27
Izmir 27
Leuven 27
Brasília 25
Chennai 25
Jinan 25
Ningbo 25
Hangzhou 24
Lappeenranta 24
Stockholm 24
Lauterbourg 22
Denver 20
Dhaka 19
Johannesburg 19
Pisa 19
Boston 18
Brno 18
Frankfurt am Main 18
Lahore 18
Amman 17
Amsterdam 17
Guayaquil 17
Portsmouth 17
Orem 16
Totale 31.655
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.198
Markers of beta cell function in type 1 diabetes mellitus 615
Urban diabetes: The case of the metropolitan area of Rome 436
null 398
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. 310
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 302
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 290
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 289
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 279
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 278
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 272
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 272
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 268
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 268
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 265
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 264
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 262
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 261
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 256
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 254
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 254
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 248
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 246
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 243
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 239
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 238
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 235
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes 234
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 231
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 229
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 227
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 225
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 225
MicroRNAs: markers of β-cell stress and autoimmunity 225
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 221
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 220
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 218
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 218
Prognostic bioindicators in severe COVID-19 patients 218
A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies 216
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 216
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment 215
Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects 214
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 214
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 213
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 211
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 210
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 205
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 205
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 204
Endocrine actions of osteocalcin 203
A prozone phenomenon interferes in islet cell antibody detection: direct comparison of two methods in subjects at risk of diabetes and in insulin dependent diabetics at onset. 202
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 201
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. 200
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 200
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 199
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 198
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 196
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 195
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study 194
Guidelines for the treatment and management of new-onset diabetes after transplantation 193
Coxsackieviruses and Insulitis 193
A novel neuroendocrine cell surface glycoprotein: identification, isolation, and initial characterization 192
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans 191
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 189
Acute onset of seeming IDDM in an AIDS patient 188
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 188
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 185
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. 185
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 185
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells 184
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 183
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 183
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial 183
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 182
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 181
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 180
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 180
Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. 178
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 177
Non-coding RNAs: novel players in insulin resistance and related diseases 177
Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes 177
Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas 177
Viral Infections and diabetes 175
Fighting diabetic foot ulcers—The diabetologist: A king maker of the fight 175
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients 174
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 173
The case for virus-induced type 1 diabetes 172
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. 171
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy 171
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease 171
Incretin Hormones and Beta-cell mass expansion: what we know and what is missing? 171
Dietary supplementation with high doses of regular vitamin D3 safely reduces Diabetes incidence in nod mice when given early and long-term. 170
Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency: Italian association study and meta-analysis of European studies. 169
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010" 169
Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines. 169
Upregulation of mitochondrial peripheral benzodiazepine receptor expression by cytokine-induced damage of human pancreatic islets 168
Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab 168
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial 167
La prevenzione del diabete mellito di tipo 1 166
Totale 22.872
Categoria #
all - tutte 139.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.278


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.999 0 0 0 0 0 478 234 703 530 372 344 338
2021/20223.296 260 556 209 289 117 101 173 105 145 317 320 704
2022/20234.482 282 318 472 645 475 929 66 353 474 165 192 111
2023/20243.121 149 109 245 133 160 843 967 99 25 124 39 228
2024/20256.875 133 387 620 430 741 347 219 467 659 329 675 1.868
2025/202610.474 1.262 2.233 2.626 1.549 2.531 273 0 0 0 0 0 0
Totale 45.822